Janus Kinase Inhibitor

All categories
DBCAT003500Therapeutic categoryL04AF

Agents that inhibit JANUS KINASES. A DrugBank category of 16 drugs. 14 of them are approved.

ATC classification
Also known as
Janus-associated kinase (JAK) inhibitors
Drugs

What you can answer from here — as of July 17, 2023

16DrugsEach linked to its full drug card
Listed above
14Drug targetsEvery drug–target pair in the class, with bond type
Sign in
427Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
3Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Janus Kinase Inhibitor share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In